Literature DB >> 2042062

Chemotherapy of ovarian cancer.

R F Ozols1, R C Young.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2042062

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  16 in total

1.  Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.

Authors:  Jeremy Chien; Giovanni Aletti; Alfonso Baldi; Vincenzo Catalano; Pietro Muretto; Gary L Keeney; Kimberly R Kalli; Julie Staub; Michael Ehrmann; William A Cliby; Yean Kit Lee; Keith C Bible; Lynn C Hartmann; Scott H Kaufmann; Viji Shridhar
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

2.  Peritoneal carcinomatosis from adenocarcinoma of the colon.

Authors:  P H Sugarbaker; M E Schellinx; D Chang; P Koslowe; M von Meyerfeldt
Journal:  World J Surg       Date:  1996-06       Impact factor: 3.352

3.  DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status.

Authors:  P De Feudis; D Debernardis; P Beccaglia; M Valenti; E Graniela Siré; D Arzani; S Stanzione; S Parodi; M D'Incalci; P Russo; M Broggini
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Combination treatment of cis- and carboplatin in cancers restricted to the peritoneal cavity in the rat.

Authors:  G Los; L Tuyt; M van Vugt; J Schornagel; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

Authors:  A K Godwin; A Meister; P J O'Dwyer; C S Huang; T C Hamilton; M E Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

6.  An XPG DNA repair defect causing mutagen hypersensitivity in mouse leukemia L1210 cells.

Authors:  J A Vilpo; L M Vilpo; D E Szymkowski; A O'Donovan; R D Wood
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

Review 7.  Quality of life in patients with ovarian cancer: current state of research.

Authors:  A Montazeri; J McEwen; C R Gillis
Journal:  Support Care Cancer       Date:  1996-05       Impact factor: 3.603

8.  Differential expressions of adhesive molecules and proteases define mechanisms of ovarian tumor cell matrix penetration/invasion.

Authors:  Youngjoo Kwon; Edna Cukierman; Andrew K Godwin
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

9.  Relationship between folate-binding protein expression and cisplatin sensitivity in ovarian carcinoma cell lines.

Authors:  F Ottone; S Miotti; C Bottini; M Bagnoli; P Perego; M I Colnaghi; S Ménard
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.

Authors:  A G van der Zee; B van Ommen; C Meijer; H Hollema; P J van Bladeren; E G de Vries
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.